Introduction
The recent Medicare drug price negotiations mark a historic step forward in lowering prescription costs for millions of Americans. For the first time, Medicare has successfully negotiated significant discounts on some of the most widely used medications, with reductions as high as 79%. Yet, a striking reality remains: when comparing U.S. drug prices vs Canada, Americans are still paying significantly more, often double or even triple, for the same prescriptions.
This blog explores why these differences exist, what the numbers really show, and how Smaltz Insurance can help individuals navigate their coverage options to reduce out-of-pocket costs.
Why the Gap Exists in U.S. Drug Prices vs Canada
Despite the progress in Medicare negotiations, Americans continue to face higher costs than their northern neighbors. Here’s why:
1. Negotiation & Regulation in Canada
In Canada, drug prices are heavily regulated through a combination of government negotiation, cost-effectiveness reviews, and oversight by the Patented Medicine Prices Review Board (PMPRB). This body ensures that drug manufacturers cannot charge above a set maximum, keeping costs more predictable and affordable for Canadians.
2. U.S. System Complexity
The U.S. system historically lacked centralized negotiation power for Medicare. Instead, it relied on insurers and pharmacy benefit managers (PBMs), which often led to inflated list prices. Although Medicare’s new negotiation authority is a major reform, the structural complexity of the U.S. system still drives up costs compared to Canada.
3. Savings Still Significant—But Not Enough
The negotiated price cuts are substantial:
- Januvia: 79% reduction
- Fiasp/NovoLog: 76% reduction
- Enbrel: 67% reduction
Even with these drops, the U.S. is still paying more than peer countries. This shows that while the reform helps, the underlying cost gap remains.
4. Relative High Costs Persist
A Reuters analysis notes that even with the new negotiated rates, U.S. drug prices vs Canada remain “on average more than double.” For patients, this means relief is real but still limited compared to what Canadians pay.
U.S. Drug Prices vs Canada: A Direct Comparison
Here’s a closer look at how much Americans will still pay under Medicare’s negotiated rates in 2026 compared to Canada:
| Drug | U.S. Medicare Price (30-day, 2026) | Canadian Price (Avg.) |
|---|---|---|
| Eliquis | $231 | ~$72 |
| Jardiance | $197 | ~$61 |
| Xarelto | $197 | ~$63 |
| Januvia | $113 | ~$72 |
| Farxiga | $179 | ~$60 |
| Entresto | $295 | ~$162 |
| Enbrel | $2,355 | ~$1,049 |
| Imbruvica | $9,319 | ~$5,955 |
| Stelara | $4,695 | ~$3,353 |
| Fiasp/NovoLog | $119 | ~$48 |
This comparison makes it clear: while savings are meaningful, the U.S. drug prices vs Canada gap remains striking.
Frequently Asked Questions (FAQs)
Q1: Why are U.S. drug prices vs Canada still so different, even after Medicare negotiations?
A1: Canada uses strict government regulations and boards to set maximum drug prices, while the U.S. relies on a more complex system of insurers and PBMs, leading to higher list prices.
Q2: How much did Medicare negotiations actually save patients?
A2: The savings vary by drug, but discounts range from 67% to nearly 80%. While this is a huge step forward, Americans are still paying double or more compared to Canadians.
Q3: Does this mean prescription drugs will finally be affordable in the U.S.?
A3: Affordability is improving, but the gap shows that even after negotiation, the U.S. remains one of the most expensive countries for prescriptions. Patients may still struggle with costs depending on their insurance coverage.
Q4: What can patients do to manage their prescription drug costs?
A4: Patients should review their Medicare plans, consider supplemental coverage, and work with insurance agents who can guide them through cost-saving options.
Q5: How can Smaltz Insurance help with high prescription costs?
A5: Smaltz Insurance specializes in helping Medicare beneficiaries compare plans, maximize prescription coverage, and find options that lower out-of-pocket expenses. By understanding how negotiated prices apply to specific plans, Smaltz Insurance ensures clients get the best balance of coverage and cost savings.
The Role of Smaltz Insurance
At Smaltz Insurance, we understand how confusing the world of Medicare and prescription drug pricing can be. Our mission is to help individuals and families in our community make sense of their options. By comparing plans and analyzing how the new Medicare-negotiated prices affect your coverage, we can help reduce your out-of-pocket expenses and ensure you’re not paying more than necessary.
Whether you’re taking medications like Eliquis, Jardiance, or Enbrel, or simply preparing for the changes coming in 2026, Smaltz Insurance is here to guide you every step of the way.
Conclusion
Medicare’s 2026 negotiations mark a milestone in U.S. healthcare reform. Patients will see meaningful savings, but the reality remains that U.S. drug prices vs Canada continue to show a wide disparity. Canadians benefit from stronger government controls that keep medications more affordable, while Americans are still navigating a complex and expensive system.
For Medicare beneficiaries, the best strategy is to stay informed, compare plans, and work with trusted advisors like Smaltz Insurance. With the right support, you can maximize your benefits, reduce costs, and make sure your prescriptions remain accessible and affordable.